Importance There is no specific antiviral therapy recommended for coronavirus disease
2019 (COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate …

Background There is no specific antiviral therapy recommended for the disease caused by
SARS-CoV-2 (COVID-19). Recent publications have drawn attention to the possible benefit …

Despite several studies designed to evaluate the efficacy of chloroquine and
hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19), there is still …

Importance Data on the efficacy of hydroxychloroquine for the treatment of coronavirus
disease 2019 (COVID-19) are needed. Objective To determine whether hydroxychloroquine …

Here, we randomized 53 patients hospitalized with coronavirus disease 2019 (COVID-19) to
hydroxychloroquine therapy (at a dose of 400 mg twice daily for seven days) in addition to …

Background Effective therapies to combat coronavirus 2019 (COVID-19) are urgently
needed. Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute …

Objective In this study, we evaluated the efficacy of hydroxychloroquine (HCQ) against
coronavirus disease 2019 (COVID-19) via a randomized controlled trial (RCT) and a …

Effective therapies are urgently needed for the SARS-CoV-2 pandemic. Chloroquine has
been proved to have antiviral effect against coronavirus in vitro. In this study, we aimed to …

Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

Summary Background Previous Randomised controlled trials (RCT) evaluating chloroquine
and hydroxychloroquine in non-hospitalised COVID-19 patients have found no significant …